Antibiotics in inflammatory bowel diseases: do we know what we're doing?
- PMID: 30881898
- PMCID: PMC6382505
- DOI: 10.21037/tp.2018.11.02
Antibiotics in inflammatory bowel diseases: do we know what we're doing?
Abstract
Despite the revolution in inflammatory bowel disease (IBD) treatment over the past two decades with the advent of biological therapies, there remains a substantial proportion of patients with inadequate or unsustained response to existent therapies. The overwhelming focus of IBD therapeutics has been targeting mucosal immunity, however with the developing evidence base pointing to the role of gut microbes in the inflammatory process, renewed focus should be placed on the impact of manipulating the microbiome in IBD management. This review provides an overview of the evidence implicating bacteria in the pathogenesis of gut inflammation in IBD and provides an overview of the evidence of antibiotics in IBD treatment. We also suggest a potential role of antibiotics in clinical practice based on available evidence and clinical experience.
Keywords: Inflammatory bowel disease (IBD); antibiotics.
Conflict of interest statement
Conflicts of Interest: The author has no conflicts of interest to declare.
Similar articles
-
The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.Scand J Gastroenterol Suppl. 2001;(234):29-40. doi: 10.1080/003655201753265082. Scand J Gastroenterol Suppl. 2001. PMID: 11768558 Review.
-
Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases.Mol Nutr Food Res. 2017 Jan;61(1):10.1002/mnfr.201600129. doi: 10.1002/mnfr.201600129. Epub 2016 Aug 15. Mol Nutr Food Res. 2017. PMID: 27346644 Free PMC article. Review.
-
Gut microbiota in the pathogenesis of inflammatory bowel disease.Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29. Clin J Gastroenterol. 2018. PMID: 29285689 Review.
-
The interplay between microbes and the immune response in inflammatory bowel disease.J Physiol. 2018 Sep;596(17):3869-3882. doi: 10.1113/JP275396. Epub 2018 Jul 17. J Physiol. 2018. PMID: 29806140 Free PMC article. Review.
-
The Microbiome in Patients With Inflammatory Diseases.Clin Gastroenterol Hepatol. 2019 Jan;17(2):243-255. doi: 10.1016/j.cgh.2018.08.078. Epub 2018 Sep 7. Clin Gastroenterol Hepatol. 2019. PMID: 30196163 Review.
Cited by
-
Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.Dig Dis Sci. 2020 Mar;65(3):757-788. doi: 10.1007/s10620-020-06090-z. Dig Dis Sci. 2020. PMID: 32006212 Free PMC article. Review.
-
Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response.Int J Mol Sci. 2022 Jun 23;23(13):6966. doi: 10.3390/ijms23136966. Int J Mol Sci. 2022. PMID: 35805965 Free PMC article. Review.
-
Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects.J Clin Med. 2024 Jul 8;13(13):3977. doi: 10.3390/jcm13133977. J Clin Med. 2024. PMID: 38999541 Free PMC article. Review.
-
Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies.Int J Mol Sci. 2021 Oct 21;22(21):11365. doi: 10.3390/ijms222111365. Int J Mol Sci. 2021. PMID: 34768795 Free PMC article. Review.
-
The impact of antibiotic exposure on antibiotic resistance gene dynamics in the gut microbiota of inflammatory bowel disease patients.Front Microbiol. 2024 Apr 17;15:1382332. doi: 10.3389/fmicb.2024.1382332. eCollection 2024. Front Microbiol. 2024. PMID: 38694799 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous